CCL20, MMP14, and PCDH7 were upregulated in LUAD tumor tissues and linked to poor clinical outcomes, while BTG2, CD69, GPC3, IL7R, and NMUR1 are the opposite. The gene discussed is BTG2; the disease is neoplasm.